Intravitreal ranibizumab versus laser photocoagulation for retinopathy of prematurity: efficacy, anatomical outcomes and safety.

CONCLUSION: Intravitreal ranibizumab for ROP appears to achieve similar therapeutic effects than did laser photocoagulation, but with fewer surgical complications such as retinal detachment or macular dragging.
PMID: 30514709 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - December 4, 2018 Category: Opthalmology Authors: Kang HG, Choi EY, Byeon SH, Kim SS, Koh HJ, Lee SC, Kim M Tags: Br J Ophthalmol Source Type: research